Ixabiso elifanelekileyo leChina Medical Neutrophil Gelatinase-Associated Lipocalin (NGAL) Kit Rapid Test Kit Medical Urine Reagent

inkcazelo emfutshane:


  • Ixesha lovavanyo:Imizuzu eyi-10-15
  • Ixesha elisebenzayo:Iinyanga ezingama-24
  • Ukuchaneka:Ngaphezulu kwe-99%
  • Inkcazo:1/25 uvavanyo / ibhokisi
  • Ubushushu bokugcina :2℃-30℃
  • :
  • Iinkcukacha zeMveliso

    Iithegi zeMveliso

    Siqhubeleka siwenza umoya wethu wokuba "Utshintsho oluzisa ukukhula, Umgangatho ophezulu wokuqinisekisa ukuziphilisa, umvuzo wentengiso yoLawulo, Imbali yeTyala etsala abathengi ngexabiso elifanelekileyo leChina MedicalI-Neutrophil Gelatinase-Associated Lipocalin(NGAL) IKit Rapid Test Kit Medical Urine Reagent, Samkela ngokufudumeleyo amaqabane enkampani kuzo zonke iinkalo zobomi bemihla ngemihla, sinethemba lokuseka umnxeba omnandi kunye nentsebenziswano wamashishini amancinci kunye nawe kwaye ufikelele kwinjongo yokuphumelela.
    Siqhubeleka siwenza umoya wethu “wokusungula izinto ezintsha ezisa ukukhula, umgangatho ophezulu wokuqinisekisa ukuziphilisa, umvuzo wentengiso yoLawulo, imbali yetyala elitsala abathengi.China Ngal Kit, I-Neutrophil Gelatinase-Associated Lipocalin, Inkampani yethu ibambelela kumgaqo "womgangatho ophezulu, ixabiso elifanelekileyo kunye nokuhanjiswa ngexesha". Sithemba ngokunyanisekileyo ukuseka ubudlelwane obuhle bentsebenziswano kunye namaqabane ethu amatsha kunye namadala asuka kuzo zonke iindawo zehlabathi. Sinethemba lokusebenza nawe kwaye sikukhonze ngezinto zethu ezibalaseleyo kunye neenkonzo. Wamkelekile ukuba uzibandakanye nathi!
    CEA

    ikhola_conew1

     

    Iimveliso Iinkcukacha ikhowudi iyunithi uluhlu lomgca uluhlu lwereferensi Uluhlu lomgca
    Ikhithi yokuxilonga yeCarcino-embryonic antigen 25T/Ibhokisi Cea ng/ml 2-500 5

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     


  • Ngaphambili:
  • Okulandelayo: